We Analyzed Data From the Start of the COVID-19 Pandemic to 2024 – What Did We find?
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared on LinkedIn:
“So excited to share the publication in JAHA of this long-term project focused on Adjudicated Cardiovascular Events in Patients with COVID-19, the CORONA-VTE Network Study. While many studies have relied upon large dataset analyses and diagnosis codes to understand the impact of COVID-19, we chose to create a large, unique multicenter registry with adjudicated endpoints providing data from the start of the pandemic to 2024. What did we find? The hazard of cardiovascular events has not diminished, contrary to other reports, AND vaccination is associated with reduced risk. So proud of our research team and collaborators across the CORONA-VTE Network.”
Title: Adjudicated Cardiovascular Events in Patients With COVID‐19: Association With Vaccination Status and Changes over Time
Authors: Behnood Bikdeli, Darsiya Krishnathasan, Antoine Bejjani,…, Gregory Piazza
Stay updated with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis